Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Sale
Common Stock
2024-09-11$1.50/sh−7,218$10,853→ 118,283 total
Footnotes (1)
- [F1]The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.